Pain management prior authorization at Centene
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Centene pain management PA at a glance
Centene reviews pain management PA submissions against its medical policy library, with rules drawn primarily from CDC 2022 Opioid Prescribing Guideline + SAMHSA TIP-63 for MOUD. Centene-specific context: Largest Medicaid MCO in US. Markets under Ambetter (ACA), Wellcare (MA), and state-specific Medicaid brands. State-specific appeal processes vary; check state Medicaid handbook.
Documentation packet — what to send
- Pain diagnosis with ICD-10
- PDMP query result
- UDS where applicable
- Functional / PEG score baseline and follow-up
- Prior non-opioid trials with response
- For MOUD: SUD diagnosis + counselling plan
Common denial patterns to pre-empt
Patterns observed in pain management across payers, and where Centene's book of business overlaps:
- Opioid: MME daily limit exceeded (CDC recommendation)
- Opioid: PDMP query not documented
- Quantity limits and refill restrictions
- Non-opioid alternatives not tried
- Suboxone: SUD diagnosis without counselling-bundle requirement
Appeal angles when Centene denies
- CDC 2022 Opioid Prescribing Guideline (NOT the 2016 — superseded)
- PDMP query documented + UDS as appropriate
- Documented failure of non-opioid alternatives
- Functional improvement (PEG score) on prior regimen
Peer-to-peer prep
- Cite the 2022 CDC guideline (NOT 2016)
- Have PDMP query result and UDS on screen
- Document functional improvement (PEG score)
- For Suboxone: cite SAMHSA TIP-63 and explicitly disconnect access from counselling availability if that's the rejection lever
Drug-specific PA criteria at Centene
Deep dives on each drug's PA criteria at Centene:
Frequently asked questions
What documentation does Centene need for pain management prior authorizations?
Centene's PA packet for pain management typically includes: Pain diagnosis with ICD-10; PDMP query result; UDS where applicable; Functional / PEG score baseline and follow-up. CDC 2022 Opioid Prescribing Guideline + SAMHSA TIP-63 for MOUD citations strengthen the submission.
What's the turnaround at Centene?
Centene standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Medicare Advantage extension rule under 42 CFR Part 422 may add 14 days. Internal appeal window if denied: 60 days.
Which pain management drugs does Centene most often PA-restrict?
Top targets in pain management: buprenorphine, naltrexone. Each follows the per-drug step therapy + documentation requirements published in Centene's medical policy library.
How do I prep a peer-to-peer with Centene in pain management?
Cite the 2022 CDC guideline (NOT 2016) Have PDMP query result and UDS on screen Have the policy URL and the patient's chart open before the call.
Generate a Pain management PA packet
Open ApprovalHelp — generate a pain management PA packet tailored to Centene's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com